Skip to main content

Table 1 Data and outcome for RSV-PCR positive preterm infants

From: An outbreak of RSV infections in a neonatology clinic during the RSV-season

Patient (P)

26–27 GW

31–34 GW

BW (g)

Days

BPD

Palivizumab

RSV - PCR I

RSV - PCR II

RSV related symptoms

MV / O2

Bacterial

Co-infection

RSV-outcome

1

Yes

1050

95

Severe

3

(+)

(+)

Severe LRTI

Pneumonia

MV

Enterobacter cloacae, MRSE (tracheal probe)

Prolonged hospitalization

2

Yes

840

84

Moderate

1

(+)

(+)

Severe LRTI

Pneumonia

MV

Stenotrofomonas

maltofilia (tracheal probe)

Prolonged hospitalization

3

Yes

1410

46

(+)

No data

LRTI (mild)

O2

Recovered

4

Yes

1410

23

(+)

(+)

LRTI (moderate)

Pneumonia

O2

Recovered

5

Yes

1470

33

(+)

(+)

LRTI (moderate)

O2

Recovered

6

Yes

1100

69

Moderate

1

(+)

LRTI (moderate)

O2

Recovered

7

Yes

850

69

Mild

1

(+)

No symptoms

Healthy

  1. P Patient N, GW gestational weeks at birth, BW birthweight, Days days after birth with 1st positive RSV-PCR, BPD Bronchopulmonary Dysplasia (O2 at 36 GW), Palivizumab number of applications before the 1st positive RSV-PCR test, RSV-PCR I and II first and second RSV-PCR test, MV/O2 Mechanical Ventilation/ Oxygen supplementation, LRTI Lower Respiratory Tract Infection;